Works by Kato, Ryoji


Results: 21
    1
    2
    3
    4
    5
    6
    7

    Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis.

    Published in:
    Clinical & Experimental Metastasis, 2014, v. 31, n. 5, p. 543, doi. 10.1007/s10585-014-9648-3
    By:
    • Fujimoto, Daichi;
    • Ueda, Hiroyuki;
    • Shimizu, Ryoko;
    • Kato, Ryoji;
    • Otoshi, Takehiro;
    • Kawamura, Takahisa;
    • Tamai, Koji;
    • Shibata, Yumi;
    • Matsumoto, Takeshi;
    • Nagata, Kazuma;
    • Otsuka, Kyoko;
    • Nakagawa, Atsushi;
    • Otsuka, Kojiro;
    • Katakami, Nobuyuki;
    • Tomii, Keisuke
    Publication type:
    Article
    8
    9
    10

    U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation.

    Published in:
    2020
    By:
    • Koji Haratani;
    • Kimio Yonesaka;
    • Shiki Takamura;
    • Osamu Maenishi;
    • Ryoji Kato;
    • Naoki Takegawa;
    • Hisato Kawakami;
    • Kaoru Tanaka;
    • Hidetoshi Hayashi;
    • Masayuki Takeda;
    • Naoyuki Maeda;
    • Takashi Kagari;
    • Kenji Hirotani;
    • Junji Tsurutani;
    • Kazuto Nishio;
    • Katsumi Doi;
    • Masaaki Miyazawa;
    • Kazuhiko Nakagawa;
    • Haratani, Koji;
    • Yonesaka, Kimio
    Publication type:
    journal article
    11

    U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation.

    Published in:
    Journal of Clinical Investigation, 2020, v. 130, n. 1, p. 374, doi. 10.1172/JCI126598
    By:
    • Koji Haratani;
    • Kimio Yonesaka;
    • Shiki Takamura;
    • Osamu Maenishi;
    • Ryoji Kato;
    • Naoki Takegawa;
    • Hisato Kawakami;
    • Kaoru Tanaka;
    • Hidetoshi Hayashi;
    • Masayuki Takeda;
    • Naoyuki Maeda;
    • Takashi Kagari;
    • Kenji Hirotani;
    • Junji Tsurutani;
    • Kazuto Nishio;
    • Katsumi Doi;
    • Masaaki Miyazawa;
    • Kazuhiko Nakagawa
    Publication type:
    Article
    12

    The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 6, p. 1159, doi. 10.1007/s00280-014-2590-x
    By:
    • Shimizu, Ryoko;
    • Fujimoto, Daichi;
    • Kato, Ryoji;
    • Otoshi, Takehiro;
    • Kawamura, Takahisa;
    • Tamai, Koji;
    • Matsumoto, Takeshi;
    • Nagata, Kazuma;
    • Otsuka, Kyoko;
    • Nakagawa, Atsushi;
    • Otsuka, Kojiro;
    • Katakami, Nobuyuki;
    • Tomii, Keisuke
    Publication type:
    Article
    13
    14
    15
    16

    Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors.

    Published in:
    Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-55939-5
    By:
    • Yonesaka, Kimio;
    • Iwama, Eiji;
    • Hayashi, Hidetoshi;
    • Suzuki, Shinichiro;
    • Kato, Ryoji;
    • Watanabe, Satomi;
    • Takahama, Takayuki;
    • Tanizaki, Junko;
    • Tanaka, Kaoru;
    • Takeda, Masayuki;
    • Sakai, Kazuko;
    • Azuma, Koichi;
    • Chiba, Yasutaka;
    • Atagi, Shinji;
    • Nishio, Kazuto;
    • Okamoto, Isamu;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    17
    18
    19

    CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M–positive lung cancer after osimertinib.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 9, p. 1628, doi. 10.1007/s10147-021-01947-3
    By:
    • Kato, Ryoji;
    • Hayashi, Hidetoshi;
    • Sakai, Kazuko;
    • Suzuki, Shinichiro;
    • Haratani, Koji;
    • Takahama, Takayuki;
    • Tanizaki, Junko;
    • Nonagase, Yoshikane;
    • Tanaka, Kaoru;
    • Yoshida, Takeshi;
    • Takeda, Masayuki;
    • Yonesaka, Kimio;
    • Kaneda, Hiroyasu;
    • Nishio, Kazuto;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    20

    Gamma‐aminobutyric acid transaminase genetic polymorphism is a candidate locus for responsiveness to opioid analgesics in patients with cancer pain: An exploratory study.

    Published in:
    Neuropsychopharmacology Reports, 2018, v. 38, n. 4, p. 175, doi. 10.1002/npr2.12030
    By:
    • Yokoshima, Yaeko;
    • Sumitani, Masahiko;
    • Nishizawa, Daisuke;
    • Nagashima, Makoto;
    • Ikeda, Kazutaka;
    • Kato, Ryoji;
    • Hozumi, Jun;
    • Abe, Hiroaki;
    • Azuma, Kenji;
    • Tsuchida, Rikuhei;
    • Yamada, Yoshitsugu;
    • Ogawa, Setsuro;
    • Hattori, Seiji;
    • Takarada, Junko;
    • Fujiwara, Yasuhiro;
    • Hirose, Munetaka;
    • Hosokawa, Toyoshi;
    • Ueno, Hiroshi;
    • Mashimo, Takashi;
    • Saitoh, Youichi
    Publication type:
    Article
    21